EA200970487A1 - Применение пролекарств аналогов гамк для лечения заболеваний - Google Patents
Применение пролекарств аналогов гамк для лечения заболеванийInfo
- Publication number
- EA200970487A1 EA200970487A1 EA200970487A EA200970487A EA200970487A1 EA 200970487 A1 EA200970487 A1 EA 200970487A1 EA 200970487 A EA200970487 A EA 200970487A EA 200970487 A EA200970487 A EA 200970487A EA 200970487 A1 EA200970487 A1 EA 200970487A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- treatment
- diseases
- application
- disease
- gaba analogue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/14—Antitussive agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
Описаны способы применения пролекарств аналогов ГАМК и их фармацевтических композиций для лечения мигрени, фибромиалгии, бокового амиотрофического склероза, синдрома раздраженного кишечника, социальной фобии, болезни Паркинсона, астмы, кашля или хронического обструктивного легочного заболевания и фармацевтические композиции пролекарств аналогов ГАМК, применяемых при лечении мигрени, фибромиалгии, бокового амиотрофического склероза, синдрома раздраженного кишечника, социальной фобии, болезни Паркинсона, астмы, кашля или хронического обструктивного легочного заболевания.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US87356106P | 2006-12-08 | 2006-12-08 | |
PCT/US2007/024944 WO2008073257A1 (en) | 2006-12-08 | 2007-12-06 | Use of prodrugs of gaba analogs for treating diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200970487A1 true EA200970487A1 (ru) | 2009-12-30 |
Family
ID=39186816
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200970487A EA200970487A1 (ru) | 2006-12-08 | 2007-12-06 | Применение пролекарств аналогов гамк для лечения заболеваний |
Country Status (13)
Country | Link |
---|---|
US (2) | US20080161393A1 (ru) |
EP (1) | EP2101752A1 (ru) |
JP (1) | JP2010512314A (ru) |
CN (1) | CN101652133A (ru) |
AR (1) | AR064212A1 (ru) |
AU (1) | AU2007332904A1 (ru) |
BR (1) | BRPI0720252A2 (ru) |
CA (1) | CA2672044A1 (ru) |
EA (1) | EA200970487A1 (ru) |
MX (1) | MX2009006080A (ru) |
PE (1) | PE20081389A1 (ru) |
TW (1) | TW200845959A (ru) |
WO (1) | WO2008073257A1 (ru) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8048917B2 (en) * | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US20060159743A1 (en) * | 2001-10-25 | 2006-07-20 | Depomed, Inc. | Methods of treating non-nociceptive pain states with gastric retentive gabapentin |
TWI312285B (en) * | 2001-10-25 | 2009-07-21 | Depomed Inc | Methods of treatment using a gastric retained gabapentin dosage |
US7612112B2 (en) | 2001-10-25 | 2009-11-03 | Depomed, Inc. | Methods of treatment using a gastric retained gabapentin dosage |
US7025745B2 (en) * | 2002-10-07 | 2006-04-11 | Advanced Cardiovascular Systems, Inc. | Method of making a catheter balloon using a tapered mandrel |
KR20060119971A (ko) * | 2003-09-11 | 2006-11-24 | 제노포트 인코포레이티드 | Gaba 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방 |
PL1677767T3 (pl) * | 2003-10-14 | 2011-12-30 | Xenoport Inc | Krystaliczna postać analogu kwasu gamma-aminomasłowego |
KR101228399B1 (ko) | 2004-11-04 | 2013-01-31 | 제노포트 인코포레이티드 | 가바펜틴 프로드러그 서방성 경구 투여 형태 |
US20090176882A1 (en) | 2008-12-09 | 2009-07-09 | Depomed, Inc. | Gastric retentive gabapentin dosage forms and methods for using same |
JP2010515754A (ja) * | 2007-01-11 | 2010-05-13 | ゼノポート,インコーポレイティド | R−バクロフェンのプロドラッグの徐放性経口剤形及び治療方法 |
US7872046B2 (en) * | 2008-01-25 | 2011-01-18 | Xenoport, Inc. | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
JP5291123B2 (ja) * | 2008-01-25 | 2013-09-18 | ゼノポート,インコーポレイティド | (3s)−アミノメチル−5−ヘキサン酸プロドラッグの結晶形態及びその使用 |
US7868043B2 (en) | 2008-01-25 | 2011-01-11 | Xenoport, Inc. | Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
US8299291B2 (en) * | 2008-08-07 | 2012-10-30 | Xenoport, Inc. | Methods of synthesizing 1-(acyloxy)-alkyl carbamate prodrugs |
US7989641B2 (en) | 2008-08-07 | 2011-08-02 | Xenoport, Inc. | Methods of synthesizing N-hydroxysuccinimidyl carbonates |
CA2740087C (en) | 2008-10-08 | 2019-07-23 | Kyphia Pharmaceuticals, Inc. | Gaba conjugates and methods of use thereof |
EP2403486A1 (en) * | 2009-03-03 | 2012-01-11 | XenoPort, Inc. | Sustained release oral dosage forms of an r-baclofen prodrug |
WO2011085293A1 (en) * | 2010-01-08 | 2011-07-14 | Beth Israel Deaconess Medical Center | Methods and compositions for the treatment of migraine headaches |
WO2012083128A2 (en) * | 2010-12-16 | 2012-06-21 | The Mclean Hospital Corporation | Prevention and treatment of diseases characterized by mesencephalic dopaminergic neuron cell death |
JP2015529254A (ja) * | 2012-09-21 | 2015-10-05 | ユーダブリューエム・リサーチ・ファウンデーション,インコーポレーテッド | 喘息における気道の過敏症及び炎症を制御するための新規なgabaaアゴニスト及び使用方法 |
EP2961730A2 (en) | 2013-02-26 | 2016-01-06 | XenoPort, Inc. | Method of making 1-(acyloxy)-alkyl carbamate compounds |
WO2016187595A2 (en) * | 2015-05-20 | 2016-11-24 | Lupin Atlantis Holdings Sa | Oral pharmaceutical composition of methylergonovine |
CN107271599A (zh) * | 2016-04-08 | 2017-10-20 | 上海市刑事科学技术研究院 | 一种人唾液中地西泮及其代谢物的在线spe lc-ms/ms分析方法 |
WO2019090001A1 (en) * | 2017-11-02 | 2019-05-09 | California Institute Of Technology | Neurokinin antagonists and uses thereof |
US20210221768A1 (en) * | 2018-05-14 | 2021-07-22 | Xgene Pharmaceutical Inc. | Crystalline forms of 1-(acyloxy)-alkyl carbamate drug conjugates of naproxen and pregabalin |
DE112019007341T5 (de) * | 2019-06-20 | 2022-01-27 | Hitachi High-Tech Corporation | Substanzanalysator und substanzanalyseverfahren |
RU2709527C1 (ru) * | 2019-07-29 | 2019-12-18 | Федеральное государственное бюджетное образовательное учреждение высшего образования "Курский государственный медицинский университет" Министерства здравоохранения Российской Федерации | Применение пептида Met-Glu-His-Phe-Pro-Gly-Pro (семакса) для коррекции дисбиоза при хроническом иммобилизационном стрессе |
Family Cites Families (86)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2996431A (en) * | 1953-12-16 | 1961-08-15 | Barry Richard Henry | Friable tablet and process for manufacturing same |
US3402240A (en) * | 1957-06-25 | 1968-09-17 | Pfizer & Co C | Medicinal tablet and process of making same |
US3139383A (en) * | 1961-06-26 | 1964-06-30 | Norton Co | Encapsulated time release pellets and method for encapsulating the same |
US3962414A (en) * | 1972-04-27 | 1976-06-08 | Alza Corporation | Structured bioerodible drug delivery device |
US3845770A (en) * | 1972-06-05 | 1974-11-05 | Alza Corp | Osmatic dispensing device for releasing beneficial agent |
US3811444A (en) * | 1972-12-27 | 1974-05-21 | Alza Corp | Bioerodible ocular device |
US3916899A (en) * | 1973-04-25 | 1975-11-04 | Alza Corp | Osmotic dispensing device with maximum and minimum sizes for the passageway |
DE2336218C3 (de) * | 1973-07-17 | 1985-11-14 | Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz | Orale Arzneiform |
US3992518A (en) * | 1974-10-24 | 1976-11-16 | G. D. Searle & Co. | Method for making a microsealed delivery device |
GB1478759A (en) * | 1974-11-18 | 1977-07-06 | Alza Corp | Process for forming outlet passageways in pills using a laser |
DE2460891C2 (de) * | 1974-12-21 | 1982-09-23 | Gödecke AG, 1000 Berlin | 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
US4093709A (en) * | 1975-01-28 | 1978-06-06 | Alza Corporation | Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates) |
US4063064A (en) * | 1976-02-23 | 1977-12-13 | Coherent Radiation | Apparatus for tracking moving workpiece by a laser beam |
US4079038A (en) * | 1976-03-05 | 1978-03-14 | Alza Corporation | Poly(carbonates) |
US4066747A (en) * | 1976-04-08 | 1978-01-03 | Alza Corporation | Polymeric orthoesters housing beneficial drug for controlled release therefrom |
US4070347A (en) * | 1976-08-16 | 1978-01-24 | Alza Corporation | Poly(orthoester) co- and homopolymers and poly(orthocarbonate) co- and homopolymers having carbonyloxy functionality |
US4285987A (en) * | 1978-10-23 | 1981-08-25 | Alza Corporation | Process for manufacturing device with dispersion zone |
US4200098A (en) * | 1978-10-23 | 1980-04-29 | Alza Corporation | Osmotic system with distribution zone for dispensing beneficial agent |
US4434153A (en) * | 1982-03-22 | 1984-02-28 | Alza Corporation | Drug delivery system comprising a reservoir containing a plurality of tiny pills |
US4421736A (en) * | 1982-05-20 | 1983-12-20 | Merrel Dow Pharmaceuticals Inc. | Sustained release diethylpropion compositions |
US4721613A (en) * | 1982-12-13 | 1988-01-26 | Alza Corporation | Delivery system comprising means for shielding a multiplicity of reservoirs in selected environment of use |
DE3475065D1 (en) * | 1983-06-23 | 1988-12-15 | Merck & Co Inc | (acyloxyalkoxy) carbonyl derivatives as bioreversible prodrug moieties for primary and secondary amine functions in drugs, their preparation and pharmaceutical compositions containing said derivatives |
US4820523A (en) * | 1986-04-15 | 1989-04-11 | Warner-Lambert Company | Pharmaceutical composition |
US4752470A (en) * | 1986-11-24 | 1988-06-21 | Mehta Atul M | Controlled release indomethacin |
US4816263A (en) * | 1987-10-02 | 1989-03-28 | Alza Corporation | Dosage form for treating cardiovascular diseases comprising isradipine |
US4853229A (en) * | 1987-10-26 | 1989-08-01 | Alza Corporation | Method for adminstering tiny pills |
DE3928183A1 (de) * | 1989-08-25 | 1991-02-28 | Goedecke Ag | Lactamfreie cyclische aminosaeuren |
US5827819A (en) * | 1990-11-01 | 1998-10-27 | Oregon Health Sciences University | Covalent polar lipid conjugates with neurologically active compounds for targeting |
US6197819B1 (en) * | 1990-11-27 | 2001-03-06 | Northwestern University | Gamma amino butyric acid analogs and optical isomers |
US5698155A (en) * | 1991-05-31 | 1997-12-16 | Gs Technologies, Inc. | Method for the manufacture of pharmaceutical cellulose capsules |
US5151448A (en) * | 1991-07-12 | 1992-09-29 | Crenshaw Roger T | Method for treating premature ejaculation |
US5229135A (en) * | 1991-11-22 | 1993-07-20 | Prographarm Laboratories | Sustained release diltiazem formulation |
US5276042A (en) * | 1993-04-16 | 1994-01-04 | Crenshaw Roger T | Treatment of premature ejaculation |
US5792796A (en) * | 1994-07-27 | 1998-08-11 | Warner-Lambert Company | Methods for treating anxiety and panic |
US5597826A (en) * | 1994-09-14 | 1997-01-28 | Pfizer Inc. | Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist |
US5684018A (en) * | 1994-12-13 | 1997-11-04 | Merck & Co., Inc. | Acyloxyisopropyl carbamates as prodrugs for amine drugs |
ATE207878T1 (de) * | 1996-03-14 | 2001-11-15 | Warner Lambert Co | Zyklische aminosäure als pharmazeutische wirkstoffe |
EA001214B1 (ru) * | 1996-03-14 | 2000-12-25 | Варнер-Ламберт Компани | Новые мостиковые циклические аминокислоты как фармацевтически применимые вещества |
US5672612A (en) * | 1996-09-09 | 1997-09-30 | Pentech Pharmaceuticals, Inc. | Amorphous paroxetine composition |
US6375987B1 (en) * | 1996-10-01 | 2002-04-23 | Gattefossé, S.A. | Process for the manufacture of pharmaceutical composition with modified release of active principle comprising the matrix |
US6329429B1 (en) * | 1997-06-25 | 2001-12-11 | Warner-Lambert Company | Use of GABA analogs such as Gabapentin in the manufacture of a medicament for treating inflammatory diseases |
US6127418A (en) * | 1997-08-20 | 2000-10-03 | Warner-Lambert Company | GABA analogs to prevent and treat gastrointestinal damage |
AU8668598A (en) * | 1997-08-20 | 1999-03-08 | University Of Oklahoma, The | Gaba analogs to prevent and treat gastrointestinal damage |
FR2779651B1 (fr) * | 1998-06-16 | 2001-04-20 | Gattefosse Ets Sa | Procede pour la fabrication de comprimes a liberation prolongee de principe(s) actif(s) presentant une cinetique de dissolution d'ordre zero |
US6171615B1 (en) * | 1998-07-06 | 2001-01-09 | Gattefoss{acute over (e)} | Sustained release theophylline formulations, excipient systems and methods of production |
EP1094803A2 (en) * | 1998-07-09 | 2001-05-02 | Warner-Lambert Company | Use of gaba-analogues for treating insomia |
US6680343B1 (en) * | 1998-07-09 | 2004-01-20 | Warner-Lambert Comapny | Treatment of renal colic with GABA analogs |
US6490454B1 (en) * | 1998-08-07 | 2002-12-03 | Telefonaktiebolaget Lm Ericsson (Publ) | Downlink observed time difference measurements |
WO2000061188A1 (en) * | 1999-04-09 | 2000-10-19 | Euro-Celtique S.A. | Sodium channel blocker compositions and the use thereof |
AU3735000A (en) * | 1999-05-05 | 2000-11-21 | Warner-Lambert Company | Modulation of substance p by gaba analogs and methods relating thereto |
US6627223B2 (en) * | 2000-02-11 | 2003-09-30 | Eurand Pharmaceuticals Ltd. | Timed pulsatile drug delivery systems |
GB2362646A (en) * | 2000-05-26 | 2001-11-28 | Warner Lambert Co | Cyclic amino acid derivatives useful as pharmaceutical agents |
GB2365425A (en) * | 2000-08-01 | 2002-02-20 | Parke Davis & Co Ltd | Alkyl amino acid derivatives useful as pharmaceutical agents |
WO2002028881A1 (en) * | 2000-10-06 | 2002-04-11 | Xenoport, Inc. | Bile-acid derived compounds for providing sustained systemic concentrations of drugs after oral administration |
EP1361847A2 (en) * | 2000-10-06 | 2003-11-19 | Xenoport, Inc. | Bile-acid conjugates for providing sustained systemic concentrations of drugs |
US20020098999A1 (en) * | 2000-10-06 | 2002-07-25 | Gallop Mark A. | Compounds for sustained release of orally delivered drugs |
US20040002543A1 (en) * | 2001-02-16 | 2004-01-01 | Leslie Magnus | Compositions comprising GABA analogs and a decongestant to relieve sinus headache pain |
WO2002100392A1 (en) * | 2001-06-11 | 2002-12-19 | Xenoport, Inc. | Orally administered dosage forms of gaba analog prodrugs having reduced toxicity |
US6818787B2 (en) * | 2001-06-11 | 2004-11-16 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US8048917B2 (en) * | 2005-04-06 | 2011-11-01 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
US7186855B2 (en) * | 2001-06-11 | 2007-03-06 | Xenoport, Inc. | Prodrugs of GABA analogs, compositions and uses thereof |
RU2004117211A (ru) * | 2001-11-08 | 2005-03-27 | Сепракор, Инк. (Us) | Способы лечения депресии и других рассстройств цнс с использованием энантиомерно обогащшенных десметил-и дидесметилметаболитов циталопрама |
US7045549B2 (en) * | 2001-11-08 | 2006-05-16 | The Board Of Trustees Of The Leland Stanford Jr. University | Treatment of symptoms associated with irritable bowel syndrome |
BR0307411A (pt) * | 2002-01-31 | 2004-12-07 | Warner Lambert Co | Ligantes alfa2delta para tratar zumbidos |
WO2003080588A1 (en) * | 2002-03-20 | 2003-10-02 | Xenoport | Cyclic 1-(acyloxy)-alkyl prodrugs of gaba analogs, compositions and uses thereof |
AU2003297927A1 (en) * | 2002-12-11 | 2004-06-30 | Xenoport, Inc. | Prodrugs of fused gaba analogs, pharmaceutical compositions and uses thereof |
CA2451267A1 (en) * | 2002-12-13 | 2004-06-13 | Warner-Lambert Company Llc | Pharmaceutical uses for alpha2delta ligands |
WO2004054564A1 (en) * | 2002-12-13 | 2004-07-01 | Warner-Lambert Company Llc | Gabapentin analogues for fibromyalgia and other related disorders |
JP2006511604A (ja) * | 2002-12-13 | 2006-04-06 | ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー | 線維筋痛症及び関連する他の障害の治療のためのプレガバリン及びその誘導体 |
US20060264509A1 (en) * | 2003-03-21 | 2006-11-23 | Fraser Matthew O | Methods for treating pain using smooth muscle modulators and a2 subunit calcium channel modulators |
JP2006522146A (ja) * | 2003-03-31 | 2006-09-28 | ゼノポート,インコーポレイティド | Gaba類似体のプロドラッグを使用するのぼせの治療または予防 |
WO2005010011A2 (en) * | 2003-07-15 | 2005-02-03 | Xenoport, Inc. | Methods of synthesis of acyloxyalkyl compounds |
US7109239B2 (en) * | 2003-08-20 | 2006-09-19 | Xenoport, Inc. | Acyloxyalkyl carbamate prodrugs, methods of synthesis and use |
KR20060119971A (ko) * | 2003-09-11 | 2006-11-24 | 제노포트 인코포레이티드 | Gaba 유사체의 전구약물을 이용한 요실금의 치료및/또는 예방 |
EP1675582A1 (en) * | 2003-09-12 | 2006-07-05 | Warner-Lambert Company LLC | Combination comprising an alpha-2-delta ligand and an ssri and/or snri for treatment of depression and anxiety disorders |
SG146643A1 (en) * | 2003-09-17 | 2008-10-30 | Xenoport Inc | Treating or preventing restless legs syndrome using prodrugs of gaba analogs |
EP1670750A1 (en) * | 2003-09-25 | 2006-06-21 | Warner-Lambert Company LLC | Prodrugs of amino acids with affinity for the alpha2delta- protein |
PL1677767T3 (pl) * | 2003-10-14 | 2011-12-30 | Xenoport Inc | Krystaliczna postać analogu kwasu gamma-aminomasłowego |
US20050209319A1 (en) * | 2004-03-18 | 2005-09-22 | Xenoport, Inc. | Treatment of local pain |
KR101228399B1 (ko) * | 2004-11-04 | 2013-01-31 | 제노포트 인코포레이티드 | 가바펜틴 프로드러그 서방성 경구 투여 형태 |
US20060192353A1 (en) * | 2005-02-08 | 2006-08-31 | Schubert Peter J | Method of producing a rollover arming signal based on off-axis acceleration |
WO2007027477A2 (en) * | 2005-08-23 | 2007-03-08 | Xenoport, Inc. | Treating vulvodynia using prodrugs of gaba analogs |
US20070049626A1 (en) * | 2005-08-26 | 2007-03-01 | Tran Pierre V | Treating premature ejaculation using gabapentin and pregabalin prodrugs |
WO2008060572A1 (en) * | 2006-11-14 | 2008-05-22 | Xenoport, Inc. | Use of gabapentin and pregabalin prodrugs for treating tinnitus |
US7868043B2 (en) * | 2008-01-25 | 2011-01-11 | Xenoport, Inc. | Mesophasic forms of (3S)-aminomethyl-5-methyl-hexanoic acid prodrugs and methods of use |
US7872046B2 (en) * | 2008-01-25 | 2011-01-18 | Xenoport, Inc. | Crystalline form of a (3S)-aminomethyl-5-methyl-hexanoic acid prodrug and methods of use |
-
2007
- 2007-12-06 EA EA200970487A patent/EA200970487A1/ru unknown
- 2007-12-06 CA CA002672044A patent/CA2672044A1/en not_active Abandoned
- 2007-12-06 EP EP07867636A patent/EP2101752A1/en not_active Withdrawn
- 2007-12-06 JP JP2009540287A patent/JP2010512314A/ja active Pending
- 2007-12-06 US US12/001,067 patent/US20080161393A1/en not_active Abandoned
- 2007-12-06 CN CN200780051141A patent/CN101652133A/zh active Pending
- 2007-12-06 MX MX2009006080A patent/MX2009006080A/es not_active Application Discontinuation
- 2007-12-06 BR BRPI0720252-0A patent/BRPI0720252A2/pt not_active Application Discontinuation
- 2007-12-06 WO PCT/US2007/024944 patent/WO2008073257A1/en active Application Filing
- 2007-12-06 AU AU2007332904A patent/AU2007332904A1/en not_active Abandoned
- 2007-12-07 TW TW096146838A patent/TW200845959A/zh unknown
- 2007-12-10 PE PE2007001760A patent/PE20081389A1/es not_active Application Discontinuation
- 2007-12-10 AR ARP070105514A patent/AR064212A1/es unknown
-
2011
- 2011-10-27 US US13/283,469 patent/US20120041061A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
PE20081389A1 (es) | 2008-11-19 |
US20120041061A1 (en) | 2012-02-16 |
MX2009006080A (es) | 2009-07-14 |
CA2672044A1 (en) | 2008-06-19 |
JP2010512314A (ja) | 2010-04-22 |
EP2101752A1 (en) | 2009-09-23 |
CN101652133A (zh) | 2010-02-17 |
BRPI0720252A2 (pt) | 2014-01-07 |
US20080161393A1 (en) | 2008-07-03 |
TW200845959A (en) | 2008-12-01 |
AU2007332904A1 (en) | 2008-06-19 |
AR064212A1 (es) | 2009-03-18 |
WO2008073257A1 (en) | 2008-06-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200970487A1 (ru) | Применение пролекарств аналогов гамк для лечения заболеваний | |
NO20082026L (no) | Deazapuriner som er nyttige som inhibitorer for Janus-kinaser | |
EA200870216A1 (ru) | Амидо соединения и их применение в качестве лекарственных средств | |
NO20083501L (no) | Azaindoler som er anvendelige som inhibitorer for Janus-kinaser | |
SG170828A1 (en) | Deazapurines useful as inhibitors of janus kinases | |
MA32771B1 (fr) | Mutants fgf21 et leurs utilisations | |
EA200870019A1 (ru) | Лактамовые соединения и способы их применения | |
IL190835A0 (en) | Sulfonamide derivatives, their preparation and use | |
BR112012009214A2 (pt) | compostos | |
ATE489371T1 (de) | Benzamidglucokinaseaktivatoren | |
EA200970946A1 (ru) | Комбинированная терапия антикоагулирующего средства с соединением, которое действует как ингибитор фактора ха | |
UA92636C2 (en) | Tetrahydro-pyrimidoazepines as modulators of trpv1 | |
NO20070651L (no) | Sammensetninger av statiner med bronkodilatorer | |
ATE554084T1 (de) | N-hydroxyacrylamidverbindungen | |
CL2007003690A1 (es) | Compuestos derivados de 1-azonia-biciclo[2.2.2]octano; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de enfermedades pulmonares obstructivas cronicas. | |
ATE524450T1 (de) | 5-phenyl-isoxazol-3-carboxamid-derivate als trpv1-modulatoren | |
ATE555116T1 (de) | Ahcy-hydrolasehemmer zur behandlung von hyperhomocysteinämie | |
WO2006078576A3 (en) | Aminomethyl beta-secretase inhibitors for the treatment of alzheimer's disease | |
CL2007000789A1 (es) | Compuestos derivados de malonamida, inhibidores de la gamma-secretasa; proceso de preparacion; composicion farmaceutica; y su uso en el tratamiento de la enfermedad de alzheimer. | |
ECSP088287A (es) | Una combinación de compuestos que puede ser utilizada en el tratamiento de enfermedades respiratorias, especialmente enfermedad pulmonar obstructiva crónica (epoc) y asma | |
CY1120487T1 (el) | Νεα μεθοδος για τη θεραπεια λοιμωξεων απο ελικοβακτηριδιο του πυλωρου (η. pylori) | |
NO20070187L (no) | Oralt desintegrerende farmasoytisk preparat omfattende risperidon | |
CL2008000973A1 (es) | Compuestos derivados de 1-oxo-isoquinolina; procedimiento de preparación; composición farmacéutica; y su uso en el tratamiento de enfermedades pulmonares obstructvas crónicas (epoc) y asma. | |
WO2006086609A3 (en) | Inhibitors of tryptase | |
BRPI0516383A (pt) | derivados cìclicos de sulfonil amino e o uso dos mesmos |